Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-exposure Option for Reducing HIV in the UK: an Open-label Randomisation to Immediate or Deferred Daily Truvada for HIV Negative Gay Men.(PROUD)

NCT02065986 is registered in ClinicalTrials.gov with MRC [ycm] as lead sponsor.

NCT NCT02065986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02065986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-exposure Option for Reducing HIV in the UK: an Open-label Randomisation to Immediate or Deferred Daily Truvada for HIV Negative Gay Men.(PROUD)
Lead sponsor
MRC [ycm]
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
October 31, 2016
Enrollment
544 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv